Tirzepatide is indicated as an adjunct to diet and exercise to improve glycemic control in adult and pediatric patients with type 2 diabetes mellitus aged 10 years and older. It is the first and currently the only GIP and GLP‑1 receptor agonist proven to improve glycemic control in adults with type 2 diabetes.
Who should not use Tirzepatide?Tirzepatide is contraindicated in patients who ar···【more】
Release date:2026-05-15Recommended:15
What is Tirzepatide?Tirzepatide contains the active substance tirzepatide. It is···【more】
Release date:2026-05-15Recommended:12